Dow Jones
37.775,38 +22,07 (+0,06%) Nasdaq
15.601,50 -81,87 (-0,52%) Nikkei 225
38.079,70 +117,90 (+0,31%) EUR/USD
1,0645 -0,0001 (-0,01%) Bitcoin EUR
59.658,87 +2.098,92 (+3,65%) CMC Crypto 200
1.310,99 +425,46 (+48,05%)
BIMI Holdings Inc. (BIMI)
Dopo ore:
| Chiusura precedente | 1,4400 |
| Aperto | 1,4000 |
| Denaro | 1,0700 x 2000 |
| Lettera | 0,0000 x 0 |
| Min-Max giorno | 1,0600 - 1,4503 |
| Intervallo di 52 settimane | 0,6600 - 4,1300 |
| Volume | |
| Media Volume | 49.380 |
| Capitalizzazione | 18,765M |
| Beta (5 anni mensile) | 1,67 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -6,3900 |
| Prossima data utili | 02 mag 2024 - 06 mag 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | N/D |
- GlobeNewswire
BIMI International Medical Inc. Announces Subsidiary Phenix Bio Inc’s Appointment of ASEAN Exclusive Distributor
NEW YORK, NY, Sept. 22, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI, "BIMI"), a healthcare products and services provider today announced its subsidiary, Phenix Bio Inc., appointed Hao Mu Pte. Ltd., a Singapore company, as its exclusive distributor responsible for the distribution of Phenix's 17 herbal supplements throughout the Association of Southeast Asian Nations (ASEAN) 10 member countries. Pursuant to the terms of a sales agreement entered on September 20, 2023,
- GlobeNewswire
BIMI Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)
NEW YORK, Aug. 24, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (the “Company”) today announced that on August 22, 2023, the Company received a notification letter from The Nasdaq Stock Market LLC (“Nasdaq”) stating that, because the Company has not yet filed its Quarterly Report on Form 10-Q for the period ended June 30, 2023 (the “Form 10-Q”), the Company is no longer in compliance with Nasdaq Listing Rule 5250(c)(1). Nasdaq Listing Rule 5250(c)(1) requires listed companies to time
- GlobeNewswire
BIMI International Medical Inc. Announces Strategic Partnership by its Phenix Bio Inc. Subsidiary with China Duty Free Group
NEW YORK, NY, Aug. 07, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI, “BIMI”), a leading global provider of healthcare services and innovative medical solutions, today announced the formation of a strategic partnership between its subsidiary, Phenix Bio Inc. (“Phenix”) and China Duty Free Group (“CDFG”), one of the largest and most influential state-owned duty-free retail enterprises in China. The Purchase Agreement between Phenix and CDFG, which became effective on Augu
